Safety of Lovastatin/Extended Release Niacin Compared With Lovastatin Alone, Atorvastatin Alone, Pravastatin Alone, and Simvastatin Alone (from the United States Food and Drug Administration Adverse Event Reporting System)
Year: 2006
Type: article
Study design: Observational Study
Authors: Alawi A. Alsheikh-Ali, Richard H. Karas
Institutions: Tufts University, Tufts Medical Center
Language: English
Subfield: Toxicology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W1976424587
